At a Glance

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers.

AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand^®, RESORBA^®, LiquiBandFix8^®, LIQUIFIX^™, Peters Surgical, Ifabond, Vitalitec and Seal-G^®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal^® brand as well as under white label.

Since 2019, the Group has made seven acquisitions:

Sealantis, an Israeli medical device company with a patent-protected sealant technology platform

Biomatlante, an established French developer and manufacturer of innovative surgical biomaterial technologies

Raleigh, a UK leading coater and converter of materials predominately for woundcare and bio-diagnostic products

AFS Medical, an Austrian specialist distributor of minimally invasive surgical technology

Connexicon, an Irish tissue adhesives specialist

Syntacoll, a specialist in collagen-based surgical implants

Peters Surgical, a global provider of specialty surgical sutures, mechanical haemostasis and internal cyanoacrylate devices. 

AMS’s products, manufactured in the UK, Germany, France, the Netherlands, Thailand, India, the Czech Republic and Israel, are sold globally via a network of multinational or regional partners and distributors, as well as via AMS’s own direct sales forces in the UK, Germany, Austria, France, Poland, Benelux, India, the Czech Republic and Russia. The Group has R&D innovation hubs in the UK, Ireland, Germany, France and Israel. Established in 1991, the Group has more than 1,700 employees.

We operate in the global tissue-healing technologies market. The market is growing steadily, driven by an increasingly ageing population and advances in technology.